A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy

Clinical trial NCT07564401 · RECRUITING

Trial details

NCT number: NCT07564401
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Extensive-stage Small Cell Lung Cancer (ES-SCLC)

Start date: 2026-06-16
Primary completion: 2031-03-03
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.